UK markets closed

Eli Lilly and Company (LLY.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
682.60-30.40 (-4.26%)
At close: 05:35PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
35,932,100
34,124,100
28,541,400
28,318,400
24,539,800
Cost of revenue
7,129,000
7,082,200
6,629,800
7,312,800
5,483,300
Gross profit
28,803,100
27,041,900
21,911,600
21,005,600
19,056,500
Operating expenses
Research development
9,851,100
9,313,400
7,190,800
6,930,700
6,085,700
Selling general and administrative
7,143,900
6,941,200
6,067,500
6,141,900
5,869,400
Total operating expenses
16,995,000
16,254,600
13,258,300
13,072,600
11,955,100
Operating income or loss
11,808,100
10,787,300
8,653,300
7,933,000
7,101,400
Interest expense
562,700
485,900
331,600
339,800
359,600
Total other income/expenses net
-3,869,600
-3,920,400
-1,578,100
-1,463,100
455,100
Income before tax
7,561,000
6,554,600
6,806,400
6,155,500
7,229,900
Income tax expense
1,422,600
1,314,200
561,600
573,800
1,036,200
Income from continuing operations
6,138,400
5,240,400
6,244,800
5,581,700
6,193,700
Net income
6,138,400
5,240,400
6,244,800
5,581,700
6,193,700
Net income available to common shareholders
6,138,400
5,240,400
6,244,800
5,581,700
6,193,700
Basic EPS
5.54
-
6.93
6.15
6.82
Diluted EPS
5.52
-
6.90
6.12
6.79
Basic average shares
900,536
-
901,736
906,963
907,634
Diluted average shares
903,569
-
904,619
911,681
912,505